New horizons in pharmaceutical regulation
- PMID: 22743964
- DOI: 10.1038/nrd3787
New horizons in pharmaceutical regulation
Abstract
A life cycle approach to pharmaceutical regulation, in which the benefit-risk balance of new drugs continues to be robustly assessed following market approval, is emerging in both the United States and Europe.
References
-
- N Engl J Med. 2009 Apr 2;360(14):1378-80 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical